Evolent Health (EVH) Misses Q1 EPS by 2c

Evolent Health (NYSE: EVH) reported Q1 EPS of $0.06, $0.02 worse than the analyst estimate of $0.08. Revenue for the quarter came in at $483.65 million versus the consensus estimate of $460.58 million.

For earnings history and earnings-related data on Evolent Health (EVH) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
• CPS Technologies signs 80,000-sq-ft lease in Attleboro, Massachusetts